Eduardo A. Donadi

Dr. Eduardo A. Donadi


Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2010 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
EDEduardo A. Donadi
Eduardo A. Donadi
ECErick Castelli
Erick Castelli
AAAntonio Arnaiz-Villena
Antonio Arnaiz-Villena
MRMichel Roger
Michel Roger
DRDiego Rey
Diego Rey
Philippe MoreauPhilippe Moreau
Philippe Moreau
The HLA-G gene displays several peculiarities that are distinct from those of classical HLA class I genes. The unique structure of the HLA-G molecule permits a restricted peptide presentation and allows the modulation of the cells of the immune system. Although polymorphic sites may potentially influence all biological functions of HLA-G, those present at the promoter and 3′ untranslated regions have been particularly studied in experimental and pathological conditions. The relatively low polymorphism observed in the MHC-G coding region both in humans and apes may represent a strong selective pressure for invariance, whereas, in regulatory regions several lines of evidence support the role of balancing selection. Since HLA-G has immunomodulatory properties, the understanding of gene regulation and the role of polymorphic sites on gene function may permit an individualized approach for the future use of HLA-G for therapeutic purposes.

1 October 2009 in Genes & Immunity
Verified
Journal Article
Closed access
PDF file
ECErick Castelli
Erick Castelli
CMCelso Teixeira Mendes-Junior
Celso Teixeira Mendes-Junior
NDN H S Deghaide
N H S Deghaide
RAR S de Albuquerque
R S de Albuquerque
YMYara Costa Netto Muniz
Yara Costa Netto Muniz
EDEduardo A. Donadi
Eduardo A. Donadi

25 October 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GMGustavo Martelli-Palomino
Gustavo Martelli-Palomino
JPJoao A. Pancotto
Joao A. Pancotto
YMYara Costa Netto Muniz
Yara Costa Netto Muniz
CMCelso Teixeira Mendes-Junior
Celso Teixeira Mendes-Junior
ECErick Castelli
Erick Castelli
EDEduardo A. Donadi
Eduardo A. Donadi
HLA-G molecule has well-recognized tolerogenic properties, and the encoding gene shows lower frequency of polymorphism at the coding region but higher variability at regulatory 5’ and 3’ untranslated (3’UTR) regions. At least three 3’UTR polymorphic sites have been associated with HLA-G mRNA regulation, including the 14 base pair (14bp) Insertion/Deletion, +3142C-G and +3187A-G. We studied the association of polymorphic sites at 3’UTR (sequencing analysis, encompassing the 14bp Ins-Del/+3003T-C/+3010C-G/+3027C-A/+3035C-T/+3142C-G/+3187A-G/+3196C-G polymorphic sites) with plasma soluble HLA-G levels (sHLA-G, detected by ELISA) in 187 French and 153 Brazilian healthy individuals. Allele and genotype frequencies were closely similar in both populations; however, Brazilians showed a higher HLA-G 3’UTR haplotype diversity. Considering sHLA-G levels in both populations altogether, individuals presenting 14bp Del/Del showed higher levels compared to 14bpIns/Ins genotype (P <0.05); those presenting +3010C/G showed higher levels compared to the +3010C-C genotype (P< 0.05); those presenting +3027C-C showed higher levels than the +3027A-A genotype (P< 0.05); and those bearing +3035C-C showed higher levels compared to the +3035C-T (P < 0.01) and +3035T-T (P < 0.05) genotypes. The analyses of 3’UTR haplotypes showed that UTR-1 (DelTGCCCGC) was associated with higher expression of sHLA-G, whereas UTR-5 (InsTCCTGAC) and UTR-7 (InsTCATGAC) with lower expression and other UTRs (UTR-2/3/4/6) exhibited intermediate levels. Since the differential expression of HLA-G may be beneficial or harmful depending on the underlying condition, the identification of individuals genetically programmed to differentially express HLA-G may help on defining novel strategies to control the immune response against the underlying disorder.

13 March 2014 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
ECErick Castelli
Erick Castelli
LVLuciana C. Veiga-Castelli
Luciana C. Veiga-Castelli
LYLayale Yaghi
Layale Yaghi
Philippe MoreauPhilippe Moreau
Philippe Moreau
EDEduardo A. Donadi
Eduardo A. Donadi
HLA-Ghas a relevant role in immune response regulation. The overall structure of theHLA-Gcoding region has been maintained during the evolution process, in which most of its variable sites are synonymous mutations or coincide with introns, preserving major functionalHLA-Gproperties. TheHLA-Gpromoter region is different from the classical class I promoters, mainly because (i) it lacks regulatory responsive elements for IFN-γand NF-κB, (ii) the proximal promoter region (within 200 bases from the first translated ATG) does not mediate transactivation by the principal HLA class I transactivation mechanisms, and (iii) the presence of identified alternative regulatory elements (heat shock, progesterone and hypoxia-responsive elements) and unidentified responsive elements for IL-10, glucocorticoids, and other transcription factors is evident. At least three variable sites in the 3′ untranslated region have been studied that may influenceHLA-Gexpression by modifying mRNA stability or microRNA binding sites, including the 14-base pair insertion/deletion, +3142C/G and +3187A/G polymorphisms. Other polymorphic sites have been described, but there are no functional studies on them. TheHLA-Gcoding region polymorphisms might influence isoform production and at least two null alleles with premature stop codons have been described. We reviewed the structure of theHLA-Gpromoter region and its implication in transcriptional gene control, the structure of theHLA-G3′UTR and the major actors of the posttranscriptional gene control, and, finally, the presence of regulatory elements in the coding region.

7 February 2012 in Autoimmunity
Verified
Journal Article
Closed access
APAlessandra Pontillo
Alessandra Pontillo
MGMartina Girardelli
Martina Girardelli
AKAnselmo J. Kamada
Anselmo J. Kamada
JPJoao A.T. Pancotto
Joao A.T. Pancotto
EDEduardo A. Donadi
Eduardo A. Donadi
PSPaula Sandrin-Garcia
Paula Sandrin-Garcia
Recent findings provide evidence of inflammasome critical role in the predisposition to autoimmune disorders. The involvement of inflammasome in the pathogenesis of systemic lupus erythematosus (SLE) has been hypothesized even if no significant association within inflammasome genes mutations or polymorphisms and lupus has been reported yet. We analyzed 14 single nucleotide polymorphisms (SNPs) within 7 inflammasome genes (NLRP1, NLRP3, NLRC4, AIM2, CARD8, CASP1, IL1B) in 144 patients affected by systemic lupus erythematosus and in 158 healthy controls from Southern Brazilian (state of São Paulo) with the aim of disclosing the possible role of inflammasome genes in the susceptibility of SLE. Our results demonstrated that NLRP1 rs2670660 SNP and the NLRP1 rs12150220-rs2670660 A-G haplotype were associated with SLE in our study population, and in particular with the development of nephritis, rash and arthritis. These findings are concordant with previously reported association of NLRP1 with vitiligo and type-1 diabetes underlining once more the involvement of NALP1 inflammasome in the pathogenesis of autoimmune disorders.

1 December 2009 in Human Immunology
Verified
Journal Article
Closed access
ECErick Castelli
Erick Castelli
Philippe MoreauPhilippe Moreau
Philippe Moreau
ACAlynne Oya e Chiromatzo
Alynne Oya e Chiromatzo
CMCelso Teixeira Mendes-Junior
Celso Teixeira Mendes-Junior
LVLuciana C. Veiga-Castelli
Luciana C. Veiga-Castelli
EDEduardo A. Donadi
Eduardo A. Donadi